Novo Nordisk warns of lower profits and sales due to Trump drug price policies

Novo Nordisk, the company that makes the weight-loss drug Wegovy, has warned that its profits and sales could be lower than expected. The company says this is because of President Donald Trump's policies aimed at lowering drug prices.

Separately, the company has appointed Jamey Millar to lead its U.S. business.